Vivek Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vivek Patel has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ambikanandan Misra
Faculty of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara 390001, Gujarat, India
7 shared publications - Rohan Lalani
Department of Pharmaceutics, Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Kalabhavan Campus, Vadodara, Gujarat, 390001, India
6 shared publications - Priyanka Bhatt
St. John Fisher University, Rochester, NY
4 shared publications Denish Bardoliwala
Department of Pharmaceutics, Faculty of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390001, India
3 shared publicationsHinal Patel
Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Kalabhavan Campus, Vadodara-390001, India
3 shared publicationsSushilkumar Patil
Department of Pharmaceutics, Faculty of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390001, India
3 shared publications
Latest Publications
- 10 August 2021
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 12 (9) , 651-670
Development of a Dry Powder for Inhalation of Nanoparticles Codelivering Cisplatin and ABCC3 siRNA in Lung Cancer
Background: The current study sought to formulate a dry powder inhalant (DPI) for pulmonary delivery of lipopolymeric nanoparticles (LPNs) consisting of cisplatin and siRNA for multidrug-resistant ... Graphical abstract
- 10 August 2021
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 12 (9) , 651-670
Development of a Dry Powder for Inhalation of Nanoparticles Codelivering Cisplatin and ABCC3 siRNA in Lung Cancer
Background: The current study sought to formulate a dry powder inhalant (DPI) for pulmonary delivery of lipopolymeric nanoparticles (LPNs) consisting of cisplatin and siRNA for multidrug-resistant ... Graphical abstract
- 1 February 2019
- Published by Elsevier in Journal of Controlled Release
- Vol. 296, 114-139
Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies
- 1 February 2019
- Published by Elsevier in Journal of Controlled Release
- Vol. 296, 114-139
Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies
- Open Access
- 16 October 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (62) , 35461-35473
Hydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics
Linear polyethylenimine (LPEI) has been well reported as a carrier for siRNA delivery. However, its applications are limited due to its highly ionized state at physiologic pH and the resultant charge mediated toxicity. The presence of ionizable secondary amines in LPE are responsible for its unique characteristics such as pH dependent solubility and positive charge. Therefore, modification of LPEI was carried out to obtain hydroxyethyl substituted LPEI with the degree of substitution ranging from 15% to 45%. The impact of modification on the physicochemical parameters of the polymer, i.e. buffer capacity, solubility, biocompatibility and stability, was evaluated. Surprisingly, despite the loss of ionizable amines, the substitution improved solubility, and even overcame the pH dependent solubility of LPEI. In addition, the conversion of secondary amines to less basic tertiary amines after substitution improved the buffer capacity, in the endosomal pH range, required for efficient endosomal escape. It also reduced erythrocyte aggregation, hemolytic potential and in vitro cytotoxicity. The in vitro studies showed enhanced cell uptake and mRNA knockdown efficiency. Thus, the proposed modification shows a simple approach to overcome the limitation of LPEI for siRNA delivery.
- 16 October 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (62) , 35461-35473
Open AccessHydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics
Linear polyethylenimine (LPEI) has been well reported as a carrier for siRNA delivery. However, its applications are limited due to its highly ionized state at physiologic pH and the resultant charge mediated toxicity. The presence of ionizable secondary amines in LPE are responsible for its unique characteristics such as pH dependent solubility and positive charge. Therefore, modification of LPEI was carried out to obtain hydroxyethyl substituted LPEI with the degree of substitution ranging from 15% to 45%. The impact of modification on the physicochemical parameters of the polymer, i.e. buffer capacity, solubility, biocompatibility and stability, was evaluated. Surprisingly, despite the loss of ionizable amines, the substitution improved solubility, and even overcame the pH dependent solubility of LPEI. In addition, the conversion of secondary amines to less basic tertiary amines after substitution improved the buffer capacity, in the endosomal pH range, required for efficient endosomal escape. It also reduced erythrocyte aggregation, hemolytic potential and in vitro cytotoxicity. The in vitro studies showed enhanced cell uptake and mRNA knockdown efficiency. Thus, the proposed modification shows a simple approach to overcome the limitation of LPEI for siRNA delivery.
- 25 September 2018
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (8) , 3609-3630
Lipid-Based Oral Formulation Strategies for Lipophilic Drugs
Partition coefficient (log P) is a key physicochemical characteristic of lipophilic drugs which plays a significant role in formulation development for oral administration. Lipid-based formulation...
- 25 September 2018
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (8) , 3609-3630
Lipid-Based Oral Formulation Strategies for Lipophilic Drugs
Partition coefficient (log P) is a key physicochemical characteristic of lipophilic drugs which plays a significant role in formulation development for oral administration. Lipid-based formulation...
- 5 September 2018
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (8) , 3550-3560
Colloidally Stable Small Unilamellar Stearyl Amine Lipoplexes for Effective BMP-9 Gene Delivery to Stem Cells for Osteogenic Differentiation
The biocompatibility of cationic liposomes has led to their clinical translation in gene delivery and their application apart from cancer to cardiovascular diseases, osteoporosis, metabolic diseases,...
- 5 September 2018
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (8) , 3550-3560
Colloidally Stable Small Unilamellar Stearyl Amine Lipoplexes for Effective BMP-9 Gene Delivery to Stem Cells for Osteogenic Differentiation
The biocompatibility of cationic liposomes has led to their clinical translation in gene delivery and their application apart from cancer to cardiovascular diseases, osteoporosis, metabolic diseases,...
- 23 April 2018
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 9 (5) , 375-386
Antimicrobial Peptide delivery: an Emerging Therapeutic for the Treatment of Burn and Wounds
The management of wounds and burns is becoming difficult using conventional therapeutics available due to resistance development by microbes. Therefore, there is an utmost need to develop therapeutic alternatives to these agents. Antimicrobial peptides have emerged as a novel class of agents for the effective management of wounds and burns due to their potent nature along with minimal chances of resistance development against them. This article focuses on highlighting the importance of these antimicrobial peptides among the various therapeutic alternatives for burns and wounds. Further, effective delivery strategies for these agents that are being employed and investigated are reported along with an overview of the importance of these agents in the coming years.
- 23 April 2018
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 9 (5) , 375-386
Antimicrobial Peptide delivery: an Emerging Therapeutic for the Treatment of Burn and Wounds
The management of wounds and burns is becoming difficult using conventional therapeutics available due to resistance development by microbes. Therefore, there is an utmost need to develop therapeutic alternatives to these agents. Antimicrobial peptides have emerged as a novel class of agents for the effective management of wounds and burns due to their potent nature along with minimal chances of resistance development against them. This article focuses on highlighting the importance of these antimicrobial peptides among the various therapeutic alternatives for burns and wounds. Further, effective delivery strategies for these agents that are being employed and investigated are reported along with an overview of the importance of these agents in the coming years.
- 23 May 2017
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 18 (5) , 426-436
Challenges in Dermal Delivery of Therapeutic Antimicrobial Protein and Peptides
Background: Protein and peptides in biological system form an important part of innate immune system and are being explored for potential use in various diseases as therapeutics. Importance of proteins and peptides as a new class of antimicrobial agents has boosted research in the field of biotechnology as potential alternative to antibiotic agents. Objective: Protein and peptides antimicrobial as a therapeutic class are structurally diverse and exhibit potent activity against microbes by various mechanisms. However, they present formidable challenge in formulation due to requirement of specific spatial configuration for their activity and stability. Thus, encapsulation of these therapeutics in various nano-systems may sustain activity along with improvement in stability. Method: The article highlights the need for antimicrobial peptides in dermal infections along with discussion of mechanism of their action. It highlights challenges faced for dermal delivery and research carried out for their successful delivery using nano-systems. Results: It is widely realized that these novel classes of therapeutic agents have tremendous market potential to emerge as an alternative to conventional antibiotic agents for combating issue of multidrug resistant microbial species. Research in their delivery aspects by use of current advances made in delivery systems through use of nanoconstructs offers much needed area for exploration and achieving success. Conclusion: As there is an urgent need for coming up with new therapeutic agents for encompassing the increased burden of microbial diseases in human population as well as their delivery challenges, research in field will give the much-needed strategic advantage against pathogenic organisms.
- 23 May 2017
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 18 (5) , 426-436
Challenges in Dermal Delivery of Therapeutic Antimicrobial Protein and Peptides
Background: Protein and peptides in biological system form an important part of innate immune system and are being explored for potential use in various diseases as therapeutics. Importance of proteins and peptides as a new class of antimicrobial agents has boosted research in the field of biotechnology as potential alternative to antibiotic agents. Objective: Protein and peptides antimicrobial as a therapeutic class are structurally diverse and exhibit potent activity against microbes by various mechanisms. However, they present formidable challenge in formulation due to requirement of specific spatial configuration for their activity and stability. Thus, encapsulation of these therapeutics in various nano-systems may sustain activity along with improvement in stability. Method: The article highlights the need for antimicrobial peptides in dermal infections along with discussion of mechanism of their action. It highlights challenges faced for dermal delivery and research carried out for their successful delivery using nano-systems. Results: It is widely realized that these novel classes of therapeutic agents have tremendous market potential to emerge as an alternative to conventional antibiotic agents for combating issue of multidrug resistant microbial species. Research in their delivery aspects by use of current advances made in delivery systems through use of nanoconstructs offers much needed area for exploration and achieving success. Conclusion: As there is an urgent need for coming up with new therapeutic agents for encompassing the increased burden of microbial diseases in human population as well as their delivery challenges, research in field will give the much-needed strategic advantage against pathogenic organisms.
- Open Access
- 11 February 2011
- Published by Defence Scientific Information and Documentation Centre in Defence Science Journal
- Vol. 61 (2) , 138-145
Contemporary Radiation Countermeasure
Contemporary Radiation Countermeasure (Review Paper)
- 11 February 2011
- Published by Defence Scientific Information and Documentation Centre in Defence Science Journal
- Vol. 61 (2) , 138-145
Open AccessContemporary Radiation Countermeasure
Contemporary Radiation Countermeasure (Review Paper)